Keeping up with the science: Innovation in the health and care system post Brexit
Article
Innovation in health – new treatments, technologies and processes – can help drive improvements in healthcare and ultimately health outcomes. We are on the cusp of a new wave of innovation driven by robotics, big data and therapeutic breakthroughs such as cell and gene therapy.
However, the history of innovation in the UK shows that the health and care system is often slow to adopt new technologies. The government has tried to address the causes of this problem, most recently through the Accelerated Access Review (AAR) and Life Sciences (Industrial) Strategy.
Although these initiatives offer a number of sensible policy suggestions, the reality is that they will fail to deliver on their potential without a Brexit deal that prioritises health and care; a new long-term funding settlement for health and care; and a clear plan for system reform in the NHS.
Related items

Empowering people to hold tech accountable
We need reform to remove structural barriers to people and civil society taking direct action against tech companies in UK courts – putting more power in the hands of people.
Earned settlement: Decision time
The government is imminently due to announce plans for a new model of ‘earned settlement’. These are expected to represent the most significant reforms to indefinite leave to remain in a generation.
What comes next: A fairer approach to primary assessment
England’s primary school accountability and assessment system is not working well for disadvantaged children.